Streamlining AdvancedMD Aimovig Prior Authorization Workflows

Klivira automates the complex AdvancedMD Aimovig prior authorization process, ensuring faster approvals and reduced administrative overhead for ambulatory specialty practices.

For practices utilizing AdvancedMD, managing prior authorizations for CGRP inhibitors like Aimovig (erenumab) presents significant challenges, often involving extensive manual data entry and complex step therapy requirements. Our platform addresses these bottlenecks, transforming a high-friction process into an efficient, automated workflow.

The Nuances of Aimovig Prior Authorization in AdvancedMD

Aimovig, a CGRP receptor antagonist for migraine prevention, frequently encounters payer-mandated step therapy and stringent documentation requirements. Within AdvancedMD, ambulatory specialty practices face the operational burden of manually compiling clinical evidence and navigating the PA submission for this critical, yet often high-cost, therapy.

Klivira's Seamless Integration with AdvancedMD for Aimovig

Klivira leverages the AdvancedMD API to integrate directly into your existing clinical and administrative workflows. This allows for automated identification of Aimovig prescriptions at the point of order entry, initiating the prior authorization process without requiring staff to leave the AdvancedMD environment.

Optimizing Aimovig Order Entry and Specialty Pharmacy Routing in AdvancedMD

Automated detection of Aimovig orders within AdvancedMD for immediate PA initiation.
Intelligent routing of ePA requests via X12 278 or Da Vinci PAS standards.
Streamlined communication with specialty pharmacies, including necessary clinical documentation.
Real-time tracking of Aimovig PA status directly accessible within the AdvancedMD context.
Reduction in manual data transcription errors between the EMR and PA submission portals.

Navigating Pharmacy vs. Medical Benefit for Aimovig in AdvancedMD

Aimovig can fall under either pharmacy or medical benefit, depending on payer contracts and administration setting. Klivira's integration with AdvancedMD helps identify the correct benefit pathway early in the process, ensuring the appropriate ePA submission method (e.g., NCPDP SCRIPT for pharmacy benefit, X12 278 for medical benefit) is utilized, preventing unnecessary delays or denials.

Automated Documentation Extraction for Aimovig PA Support

Klivira intelligently pulls relevant clinical data directly from AdvancedMD patient charts to support Aimovig prior authorizations. This includes extracting specific ICD-10 codes, medication history (especially failed generic preventives), and detailed clinical notes that substantiate medical necessity and adherence to payer criteria.

Key Data Points Klivira Extracts from AdvancedMD for Aimovig PAs

ICD-10 codes (e.g., G43.x for migraine diagnosis).
Problem list entries related to migraine type and severity.
Prior medication history, including dates and durations of failed preventive therapies.
Clinical notes detailing migraine frequency, duration, and impact on daily activities.
Patient demographics, insurance information, and provider NPI.
Lab results or imaging reports, if required by specific payer policies.

Frequently asked questions

How does Klivira initiate an Aimovig PA from AdvancedMD?

Klivira automatically detects Aimovig prescriptions as they are entered into AdvancedMD. Leveraging the AdvancedMD API, our platform extracts necessary patient and clinical data to pre-populate and initiate an ePA request, often without requiring manual intervention from your staff.

Can Klivira distinguish between pharmacy and medical benefit for Aimovig within AdvancedMD?

Yes. Klivira is designed to identify whether Aimovig will be covered under pharmacy or medical benefit based on payer rules and the specific prescription details within AdvancedMD. This ensures the correct electronic prior authorization (ePA) pathway, such as NCPDP SCRIPT or X12 278, is utilized for efficient submission.

What documentation does Klivira use from AdvancedMD to support Aimovig PAs?

Klivira extracts critical clinical documentation from AdvancedMD, including ICD-10 codes for migraine, detailed medication history (especially for step therapy requirements), and clinical notes describing migraine frequency, severity, and prior treatment failures, all to justify medical necessity for Aimovig.

Does Klivira integrate with AdvancedMD's specialty pharmacy workflows for Aimovig?

Klivira streamlines communication with specialty pharmacies by providing them with the necessary PA approval and clinical documentation directly from AdvancedMD. This ensures a smoother hand-off for Aimovig fulfillment, reducing delays often associated with manual coordination.

How does Klivira handle step therapy requirements for Aimovig in AdvancedMD?

Klivira is configured to understand common payer step therapy protocols for Aimovig. It extracts evidence of failed prior generic preventive therapies from AdvancedMD's medication history and clinical notes, automatically including this crucial information in the ePA submission to meet payer criteria.